SAM
DSCI

Symphony Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Symphony Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-35,983
Closed -$416K – 469
2014
Q2 		$416K Buy
+35,983
New +$369K 0.04% 350

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Symphony Asset Management's DSCI Position: Q3 2014 in Review

Symphony Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 35,983 shares — an estimated $416K sold.

Symphony Asset Management first reported a position in DSCI in Q2 2014 and held it in 1 quarter. The position peaked at $416K in Q2 2014. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Symphony Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Symphony Asset Management sold 35,983 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $416K.
  • Symphony Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2014 and held it in 1 quarter.
  • Symphony Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $416K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Symphony Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.